Dr. Cuneo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4302Fax+1 734-763-7370
Summary
- Dr. Kyle Cuneo studied Biological Engineering at Cornell University in Ithaca, NY. He then enrolled at Vanderbilt University School of Medicine in Nashville, TN, earning his Doctor of Medicine degree in 2007. Kyle performed his intern year in Internal Medicine at Vanderbilt University in 2008. He completed his residency in Radiation Oncology at Duke University Medical Center in 2012. Dr. Cuneo has been faculty at the University of Michigan since 2012. Dr. Cuneo is a member of the multidisciplinary teams managing patients with hepatobiliary cancers, colorectal cancers, lymphomas, and sarcomas.
Dr. Cuneo performs translational and clinical research in gastrointestinal malignancies including liver, pancreas, and colorectal cancers. He has published over 80 scientific articles in the field of oncology. Dr. Cuneo has served as Chair of the Protocol Review Committee and the GI Clinical Research Team at the Rogel Cancer Center. He has been awarded Teacher of the Year for Clinical Radiation Oncology and Radiation Biology.
Education & Training
- Duke University HospitalResidency, Radiation Oncology, 2008 - 2012
- Vanderbilt University School of MedicineClass of 2007
Certifications & Licensure
- MI State Medical License 2012 - 2025
- NC State Medical License 2008 - 2012
- American Board of Radiology Radiation Oncology
Clinical Trials
- Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy. Start of enrollment: 2020 Sep 16
Publications & Presentations
PubMed
- SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma.Ameer L Elaimy, Marwa O El-Derany, Jadyn James, Zhuwen Wang, Ashley N Pearson
JCI Insight. 2024-11-08 - PET/CT-Based Absorbed Dose Maps inY Selective Internal Radiation Therapy Correlate with Spatial Changes in Liver Function Derived from Dynamic MRI.Zhonglin Lu, Daniel F Polan, Lise Wei, Madhava P Aryal, Kellen Fitzpatrick
Journal of Nuclear Medicine. 2024-08-01 - 3 citationsIn-Depth Proteome Profiling of Small Extracellular Vesicles Isolated from Cancer Cell Lines and Patient Serum.Komal Abhange, Reta Birhanu Kitata, Jie Zhang, Yi-Ting Wang, Matthew J Gaffrey
Journal of Proteome Research. 2024-01-05
Authored Content
- High-Performance Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry for Exosome MetabolomicsJune 2018
Press Mentions
- U-m Rogel Cancer Center Names 2 New Clinical Research LeadersDecember 5th, 2024
- 3D Imaging Tracks Cancer Radiation in Real TimeJanuary 7th, 2023
- Real-Time Radiation Tracking Promises Safer Cancer TherapyJanuary 4th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: